Peptide Testing: Every Method, What It Catches, and What Vendors Skip
Nearly half of peptides purchased from online vendors fail at least one quality metric when independently tested. The reason is predictable: most COAs report HPLC purity and nothing else. That single number tells you how clean the sample is. It says nothing about whether you have the right molecule, how much active peptide is actually in the vial, or whether endotoxins are present.
Peptide testing is not one test. It is a stack of analytical methods, each targeting a different category of problem: identity, purity, content, and safety. A COA that only shows HPLC purity misses at least three of those four categories.
When we reviewed COAs across 23 research peptide vendors for our methodology, the pattern was consistent: one test, presented as comprehensive proof. Our peptide purity guide covers how to read the numbers on a COA. This article covers what produces those numbers, the instruments, the chemistry, and the specific impurities each method does and does not catch. By the end, you will know exactly what a vendor's COA covers and what it omits.
HPLC: The Purity Gatekeeper
The HPLC purity percentage is the most reported and most misunderstood number in peptide testing. Every COA lists it. Few buyers understand what it physically represents or where it goes blind.
How Reverse-Phase HPLC Works
Reverse-phase HPLC (RP-HPLC) separates compounds by hydrophobicity. The peptide sample, dissolved in a liquid mobile phase, flows through a column packed with C18 octadecyl silica beads under high pressure (50 to 600 bar). More hydrophobic molecules stick to the column longer. A gradient of increasing acetonitrile concentration with TFA at pH 2.0 gradually washes compounds off the column, each exiting at a different retention time.
A UV detector, typically set at 210 to 220 nm where the peptide bond absorbs light, records each compound as it exits. The result is a chromatogram: peaks plotted against time. Purity is calculated as the area of the main peak divided by the total area of all detected peaks, multiplied by 100.
That calculation only reflects UV-absorbing organic impurities. Water, counter-ion salts, and non-chromophore contaminants are invisible to this detector. Detection at 250 to 290 nm provides greater sensitivity for peptides containing aromatic residues (tyrosine, phenylalanine, tryptophan), but the 210 to 220 nm range remains standard because it detects the peptide bond itself.
What HPLC Catches
HPLC excels at detecting synthesis byproducts that differ in hydrophobicity from the target peptide. Deletion sequences (missing one amino acid), truncated forms (synthesis stopped early), oxidized residues like methionine sulfoxide, and deamidation products all typically produce separate peaks on the chromatogram. HPLC can distinguish peptides differing by just one amino acid when their hydrophobicity differs enough to separate in the column.
Purity grades map to specific applications. Greater than 95% is standard for quantitative receptor binding assays, NMR, and crystallography. The 90 to 95% range works for immunoassays and monoclonal antibody production. Below 80% is screening-grade territory, and below 65% is immunograde for polyclonal antibody work.
Higher purity costs increase exponentially above 95%. Each additional percentage point requires more aggressive purification, which reduces yield and raises price. For most RUO applications, 95% or above represents the practical sweet spot.
What HPLC Misses
HPLC measures separation, not identity. A deletion sequence with similar hydrophobicity to the target peptide can co-elute, appearing as part of the main peak. Your chromatogram shows 99% purity. The sample might still be the wrong molecule.
HPLC also cannot detect counter-ion salts (TFA, acetate), endotoxins, heavy metals, residual solvents, or water content. A vial could show 98% HPLC purity while containing significant non-peptide mass that HPLC simply cannot see.
HPLC is necessary. It is not sufficient.
Mass Spectrometry: Confirming What You Actually Have
If HPLC answers “how pure is this sample,” mass spectrometry answers “is this actually the right compound.” Every credible peptide testing panel should include both. If yours only has HPLC, the vendor is asking you to trust a purity number without confirming identity.
MALDI-TOF: Quick Identity Check
Matrix-Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) is the fast, economical option. The peptide is embedded in a crystalline matrix on a metal plate. A laser pulse ionizes the sample, and ions fly through a vacuum tube. Lighter ions arrive at the detector faster.
On a COA, this appears as “expected MW” versus “observed MW” with a tolerance of ±0.5 Da. A match confirms the primary structure. Any deviation flags a synthesis error, modification, or wrong compound entirely.
MALDI-TOF is highly accurate, fast, and requires minimal sample. Its limitation is resolution: it gives you total molecular weight but not internal sequence. Two peptides with the same total mass but different amino acid arrangements would look identical.
Researchers have used MALDI-TOF to identify mislabeled and substituted products in illegally distributed peptide vials, confirming its value as a rapid screening tool.
ESI-MS and MS/MS: Fragmentation Fingerprint
Electrospray Ionization MS (ESI-MS) generates multiply charged ions, making it better suited for larger peptides. When paired with tandem mass spectrometry (MS/MS), the instrument fragments the peptide and identifies individual amino acids from the fragmentation pattern. This confirms not just molecular weight but actual sequence.
MS/MS is the definitive identity test when a peptide has failed initial QC or when the claimed identity is disputed. It resolves ambiguities that MALDI-TOF cannot, particularly for larger peptides where single-amino-acid substitutions produce negligible mass differences relative to total molecular weight.
LC-MS: The Combined Standard
LC-MS couples liquid chromatography separation with mass spectrometric detection in a single instrument run. You get purity profiling and identity confirmation simultaneously. Each peak on the chromatogram gets a mass assignment, so you know what every impurity actually is.
LC-MS catches cases where HPLC shows high purity but the main peak is the wrong peptide entirely. It is the closest thing to a single-run comprehensive peptide testing method.
One caveat: LC-MS cannot reliably determine salt forms because ionization strips counterions during analysis. You will only see the free base mass.
Beyond Purity: Net Peptide Content, Water, and Residual Solvents
The gap that costs researchers the most sits between label weight and actual peptide mass. Peptide testing for purity alone does not close it.
Net Peptide Content (NPC)
Your 5mg vial does not contain 5mg of peptide. It contains 5mg of lyophilized powder, which is a mixture of peptide, counter-ion salts (primarily TFA), water, and trace solvents. Net peptide content is the percentage of that gross weight that is actual peptide.
NPC typically ranges from 70 to 90% for TFA salts and 75 to 90% for acetate salts, even for high-purity peptides. TFA counter-ions cannot be completely eliminated because TFA forms salt bonds with basic amino acid residues like arginine, lysine, and histidine. Peptides rich in these residues bind more TFA by mass, driving NPC lower. This is a chemistry constraint, not a quality failure.
The three-number formula every researcher should know:
Example: 5mg label weight, 70% NPC, 98% HPLC purity. That is 5 × 0.70 × 0.98 = 3.43mg of target peptide. Ignoring NPC produces systematic underdosing of roughly 20 to 30%.
Many vendors omit NPC from COAs because testing adds cost. Its presence is a positive quality signal. Its absence means you are guessing at your actual dose.
Karl Fischer Water Content
Lyophilized peptides are hygroscopic. They absorb moisture from air during handling and storage. Karl Fischer titration quantifies this water content through a stoichiometric reaction of iodine and sulfur dioxide with water, requiring roughly 10mg of sample material.
Target water content is below 5%. Elevated moisture accelerates degradation, particularly oxidation and aggregation, reducing shelf life and potency.
Amino Acid Analysis (AAA)
AAA is the most accurate method for determining net peptide content. The peptide undergoes acid hydrolysis, breaking it down to constituent amino acids. These are separated and quantified via ion exchange chromatography or UPLC. The result reveals both amino acid composition (confirming identity from a different angle) and absolute peptide quantity.
AAA is expensive and time-consuming. Most RUO vendors skip it entirely. When present on a COA, it indicates a vendor investing in full analytical transparency.
Residual Solvents
Peptide synthesis uses organic solvents (acetonitrile, DMF, DCM, piperidine) that can carry over into the final product and concentrate during lyophilization. Gas chromatography with mass spectrometric detection (GC-MS) quantifies these residues.
ICH Q3C guidelines set limits: DMF below 880 ppm, acetonitrile below 410 ppm, DCM below 600 ppm. These are pharmaceutical standards. RUO vendors are not required to test for solvents, and most do not.
Safety Testing: Endotoxin and Sterility
Safety testing is where peptide testing diverges most sharply between RUO and GMP grades. Most RUO COAs include zero safety data. For certain research applications, that gap directly compromises results.
Endotoxin (LAL Assay)
Endotoxins are lipopolysaccharides from the outer membrane of gram-negative bacteria. They are thermostable, meaning they survive synthesis, filtration, and lyophilization. Standard sterile filtration does not remove them.
The LAL assay (Limulus Amebocyte Lysate) detects endotoxins using an extract from horseshoe crab blood cells that triggers a clotting cascade in the presence of LPS. Results are reported in endotoxin units (EU) per vial or per milligram.
Thresholds for RUO peptides: below 5 EU per vial is excellent for sensitive assays. Between 5 and 10 is high-quality standard. Between 10 and 30 is typical for general RUO. Above 30 may compromise sensitive work.
Why this matters for research: endotoxin contamination triggers inflammatory pathways that can fabricate immunomodulatory effects, disrupts cell viability and gene expression in culture, distorts receptor binding assays, and destroys reproducibility between experiments. If your research involves immune cells or in vivo models and your COA has no endotoxin data, your results may be confounded by a variable you never measured.
Sterility Testing (USP 71)
USP 71 is the pharmaceutical reference standard for sterility. The lyophilized peptide is dissolved and incubated in growth media (tryptic soy broth) for 14 days. Any turbidity indicates contamination by bacteria, mold, or yeast.
Sterility testing is pass/fail for the absence of live organisms. Bioburden testing, by contrast, counts the number of organisms present. GMP peptides require both. RUO peptides typically require neither. Standard RUO peptides are non-sterile unless specifically ordered as sterile-filtered.
Heavy Metals: ICP-MS
Inductively Coupled Plasma Mass Spectrometry detects heavy metals at parts-per-billion sensitivity. Lead, cadmium, and arsenic are the primary concerns, with neurological, renal, and hepatic toxicity at low chronic exposure levels. USP 232 sets elemental impurity limits for pharmaceutical products.
Heavy metals are invisible to both HPLC and mass spectrometry. A clean HPLC chromatogram and a matching MS molecular weight tell you nothing about metal contamination. ICP-MS is the only way to know, and it is rarely included on RUO COAs.
Impurity Types and Which Test Catches Each
Every synthesis impurity has at least one analytical method that catches it. No single method catches them all. The complete peptide testing map follows.
Deletion sequences (missing one amino acid): HPLC separates them if hydrophobicity differs. LC-MS confirms by detecting mass minus one residue. If the deletion co-elutes on HPLC, only MS catches it.
Truncated forms (synthesis stopped early): HPLC detects shorter fragments. MS confirms lower molecular weight.
Oxidation (methionine to methionine sulfoxide): HPLC shows a shifted peak with different retention time. MS detects the characteristic +16 Da mass shift.
Deamidation (asparagine/glutamine conversion): HPLC may separate the product. High-resolution MS detects the subtle +1 Da mass difference, though this requires better-than-unit resolution.
Racemization (L to D amino acid conversion): Standard RP-HPLC is blind to this. Only chiral HPLC or optical rotation measurement can detect it. Racemized peptides show identical molecular weight on MS. This is the hardest impurity to catch and rarely tested in RUO.
Counter-ion salts (TFA, acetate): Invisible to HPLC and MS. Detected through NPC analysis or ion chromatography.
Water content: Invisible to HPLC and MS. Karl Fischer titration only.
Residual solvents: GC-MS only. Not detected by any other method on this list.
Endotoxins: LAL assay only. Invisible to every chromatographic and spectrometric method.
Heavy metals: ICP-MS only. No other standard peptide test detects them.
Microbial contamination: USP 71 sterility testing and bioburden assays. No analytical chemistry method detects viable organisms.
Reading a COA Through This Lens
A COA showing only HPLC plus MALDI gives you purity and identity. Everything else–NPC, water, solvents, endotoxin, heavy metals, sterility, racemization–is unknown.
The minimum credible COA for serious research includes HPLC (purity), MS (identity), NPC (actual peptide content), and endotoxin (LAL). Our COA verification guide breaks down how to evaluate each of these on a real document.
Vendors who provide four or more test categories are investing in transparency. Vendors providing only HPLC are giving you the cheapest possible quality signal. Both might sell pure peptides. Only one is proving it.
RUO vs. GMP Testing and How to Spot a Fake COA
RUO vs. GMP Testing Scope
Research-use-only peptides operate outside FDA oversight. No regulatory body mandates which tests a vendor must run. The vendor chooses the peptide testing scope, and most choose the minimum: HPLC purity and sometimes MS identity.
GMP-grade peptides follow full ICH compliance. Every batch gets HPLC, MS, NPC, AAA, residual solvents, endotoxin, sterility, bioburden, heavy metals, and appearance/solubility testing. This costs 5 to 10 times more per batch, which is why GMP peptides carry pharmaceutical pricing.
The practical consequence: when you buy RUO peptides, you rely entirely on the vendor's voluntary quality program. Some vendors voluntarily test to near-GMP standards. Others provide the bare minimum and charge similar prices. The COA is your only window into which category your vendor falls into.
COA Fraud Tactics
Template recycling is the most common fraud. A vendor creates one COA template and reuses it across batches, changing only the date and lot number. The chromatogram image, purity value, and MS data stay identical.
Real analytical instruments produce slightly different results every run. Identical data across batches is a fabrication signal.
Batch number gaps or sequential numbering without production scale to justify it suggests either fabricated lot numbers or extremely low production volume with high-volume sales.
Round-number purity (exactly 99.00% or 98.00%) on every batch is suspicious. Real HPLC measurements produce values like 98.37% or 99.12%. Consistent round numbers suggest the number was chosen, not measured.
Missing instrument parameters is a red flag. Legitimate chromatographic data includes column type, gradient conditions, flow rate, detection wavelength, and injection volume. A COA that reports only a purity number without method details cannot be verified or reproduced.
A named lab is not an accredited lab. Some vendors list a laboratory name that sounds credible but holds no ISO/IEC 17025 accreditation. The accreditation of the testing lab matters more than the vendor's quality claims.
Verification Checklist
Check instrument parameters. A real COA includes column specifications, mobile phase composition, gradient program, flow rate, and detection wavelength. If these are absent, the data cannot be independently evaluated.
Verify batch numbers match your vial label exactly. A COA tied to a different lot number is decoration, not verification.
Contact the testing lab independently. Search for the lab name, confirm it exists, confirm it holds relevant accreditation, and ask whether they tested that specific batch. This single step eliminates most fraudulent COAs.
Look for realistic chromatographic peaks. Real HPLC chromatograms show slight baseline noise, minor impurity peaks, and natural peak shapes. Perfectly smooth baselines with a single symmetrical peak may indicate a digitally generated image.
Our COA verification methodology and vendor reviews apply these checks systematically across every vendor we evaluate.
Frequently Asked Questions
What is the single most important peptide test?
No single peptide testing method covers everything. HPLC plus mass spectrometry is the minimum credible combination: HPLC quantifies purity, MS confirms identity. A COA missing either one should raise questions about the vendor's quality standards.
What does the HPLC purity percentage actually measure?
HPLC purity is the main peak area divided by total detected peak area. It reflects the target peptide's proportion relative to UV-visible organic impurities only. It does not account for water, counter-ion salts, residual solvents, endotoxins, or heavy metals.
How can I verify whether a COA is real?
Confirm the batch number matches your vial. Check that the COA includes method details (column type, gradient, wavelength), not just a number. Contact the testing lab directly and ask whether they analyzed that specific batch. Our COA verification guide walks through each step.
What is net peptide content and why does it matter for dosing?
NPC is the percentage of your vial's gross weight that is actual peptide, excluding counter-ion salts, water, and solvents. Typical range: 70 to 90%. A 5mg vial at 75% NPC contains 3.75mg of peptide before accounting for purity. Ignoring NPC underdoses by 20 to 30%.
Do research peptides need endotoxin testing?
For cell culture, immune assays, or in vivo research, yes. Endotoxins trigger inflammatory cascades that confound any experiment involving immune-responsive systems. Below 5 EU per vial is the target for sensitive assays. Most RUO vendors skip this test entirely.